For children's tonsillitis, many U.S. doctors have been prescribing a new drug called Analbis. The drug, a bismuth compound, has an affinity for lymph and attacks the infection in sore throats. In the last three years doctors have used it for hundreds of thousands of patients.
Last week they abruptly stopped using it. New York City health officers flashed to the nation the tragic news that at least twelve small patients who had been treated with the drug had died.
The first warning came from a Norwalk, Conn, hospital. Three baby boys, after being dosed with Analbis rectal suppositories, came down with violent...
To continue reading:
or
Log-In
